Indianapolis Clinical Site 121 — Indianapolis, Indiana

Indianapolis Clinical Site 121 is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Indianapolis Clinical Site 121 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Ono Pharma USA Inc, EMD Serono.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indianapolis Clinical Site 121?

Indianapolis Clinical Site 121 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indianapolis Clinical Site 121 conducted?

Indianapolis Clinical Site 121 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Indianapolis Clinical Site 121 accredited by Crixeo Clinical Trials?

Indianapolis Clinical Site 121 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indianapolis Clinical Site 121?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.